ChemoCentryx (CCXI) Prices 5.2M Share Common Offering at $58/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
ChemoCentryx Prices Public Offering of Common Stock
June 10, 2020 9:32 PM EDTMOUNTAIN VIEW, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq: CCXI) announced today that it has priced an underwritten public offering of 5,200,000 shares of its common stock at a price to the public of $58.00 per share. The gross proceeds to ChemoCentryx from the offering, before underwriting discounts and commissions and offering costs, are expected to be $301,600,000. ChemoCentryx has granted the underwriters a 30-day option to purchase up to an additional 780,000 shares of its common stock on the same terms and conditions. All shares of the common stock to be sold in the... More



